These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 8252351)
21. P53 tumour-suppressor gene mutations are mainly localised on exon 7 in human primary and metastatic prostate cancer. Dahiya R; Deng G; Chen KM; Chui RM; Haughney PC; Narayan P Br J Cancer; 1996 Jul; 74(2):264-8. PubMed ID: 8688333 [TBL] [Abstract][Full Text] [Related]
22. p53 protein expression in non-Hodgkin's lymphomas is infrequently related to p53 gene mutations. Oka T; Sarker AB; Teramoto N; Yoshino T; Akagi T Pathol Int; 1998 Jan; 48(1):15-21. PubMed ID: 9589459 [TBL] [Abstract][Full Text] [Related]
23. Detection of loss of heterozygosity of p53 gene in paraffin-embedded breast cancers by non-isotopic PCR-SSCP. Chen YH; Li CD; Yap EP; McGee JO J Pathol; 1995 Oct; 177(2):129-34. PubMed ID: 7490678 [TBL] [Abstract][Full Text] [Related]
24. p53 gene mutation in relation to p53 protein accumulation in male and female breast cancer. Nayak BK; Baral RN; Das BR Neoplasma; 1996; 43(5):305-10. PubMed ID: 8996549 [TBL] [Abstract][Full Text] [Related]
26. Immunohistochemical vs molecular biology methods. Complementary techniques for effective screening of p53 alterations in head and neck cancer. Calzolari A; Chiarelli I; Bianchi S; Messerini L; Gallo O; Porfirio B; Mattiuz PL Am J Clin Pathol; 1997 Jan; 107(1):7-11. PubMed ID: 8980360 [TBL] [Abstract][Full Text] [Related]
27. P-glycoprotein, HER-2/neu, and mutant p53 expression in human gynecologic tumors. Schneider J; Rubio MP; Barbazán MJ; Rodriguez-Escudero FJ; Seizinger BR; Castresana JS J Natl Cancer Inst; 1994 Jun; 86(11):850-5. PubMed ID: 7910219 [TBL] [Abstract][Full Text] [Related]
28. p53 gene alteration and protein expression in Iranian women with infiltrative ductal breast carcinoma. Pezeshki AM; Farjadian S; Talei A; Vasei M; Gharesi-Fard B; Doroudchi M; Ghaderi A Cancer Lett; 2001 Aug; 169(1):69-75. PubMed ID: 11410327 [TBL] [Abstract][Full Text] [Related]
29. p53 immunohistochemical analysis in breast cancer with four monoclonal antibodies: comparison of staining and PCR-SSCP results. Jacquemier J; Molès JP; Penault-Llorca F; Adélaide J; Torrente M; Viens P; Birnbaum D; Theillet C Br J Cancer; 1994 May; 69(5):846-52. PubMed ID: 7514027 [TBL] [Abstract][Full Text] [Related]
30. Bax expression in benign and malignant thyroid tumours: dysregulation of wild-type P53 is associated with a high Bax and P21 expression in thyroid carcinoma. Hermann S; Sturm I; Mrozek A; Klosterhalfen B; Hauptmann S; Dörken B; Daniel PT Int J Cancer; 2001 Jun; 92(6):805-11. PubMed ID: 11351299 [TBL] [Abstract][Full Text] [Related]
31. Immunohistochemical detection of mutant p53 protein in epithelial ovarian cancer using polyclonal antibody CMI: correlation with histopathology and clinical features. Renninson J; Baker BW; McGown AT; Murphy D; Norton JD; Fox BW; Crowther D Br J Cancer; 1994 Mar; 69(3):609-12. PubMed ID: 8123498 [TBL] [Abstract][Full Text] [Related]
32. Staining patterns of p53 immunohistochemistry and their biological significance in colorectal cancer. Kaserer K; Schmaus J; Bethge U; Migschitz B; Fasching S; Walch A; Herbst F; Teleky B; Wrba F J Pathol; 2000 Mar; 190(4):450-6. PubMed ID: 10699994 [TBL] [Abstract][Full Text] [Related]
33. Abnormalities of the p53 MDM2 and DCC genes in human leiomyosarcomas. Patterson H; Gill S; Fisher C; Law MG; Jayatilake H; Fletcher CD; Thomas M; Grimer R; Gusterson BA; Cooper CS Br J Cancer; 1994 Jun; 69(6):1052-8. PubMed ID: 8198970 [TBL] [Abstract][Full Text] [Related]
34. Post-thymic T cell lymphomas frequently overexpress p53 protein but infrequently exhibit p53 gene mutations. Matsushima AY; Cesarman E; Chadburn A; Knowles DM Am J Pathol; 1994 Mar; 144(3):573-84. PubMed ID: 8129043 [TBL] [Abstract][Full Text] [Related]
35. p53 mutations, protein expression and cell proliferation in squamous cell carcinomas of the head and neck. Nylander K; Nilsson P; Mehle C; Roos G Br J Cancer; 1995 Apr; 71(4):826-30. PubMed ID: 7710950 [TBL] [Abstract][Full Text] [Related]
36. [Greater sensitivity of the PCR-SSCP technique compared with immunohistochemistry for the detection of exon 5 and 6 mutations of gene 53 in breast cancer]. Dueñas González A; Cruz Hernández JJ; Abad Hernández MM; Ramos M; González Sarmiento R Med Clin (Barc); 1996 May; 106(19):721-4. PubMed ID: 8801382 [TBL] [Abstract][Full Text] [Related]
37. p53 gene alterations in special types of breast carcinoma: a molecular and immunohistochemical study in archival material. Karameris AM; Worthy E; Gorgoulis VG; Quezado M; Anastassiades OT J Pathol; 1995 Aug; 176(4):361-72. PubMed ID: 7562251 [TBL] [Abstract][Full Text] [Related]
38. p53 mutation and expression in lymphoma. Adamson DJ; Thompson WD; Dawson AA; Bennett B; Haites NE Br J Cancer; 1995 Jul; 72(1):150-4. PubMed ID: 7599045 [TBL] [Abstract][Full Text] [Related]
39. Protein accumulation and gene mutation of p53 in bilateral breast cancer. South-East Sweden Breast Cancer Group. Stenmark-Askmalm M; Gentile M; Wingren S; Ståhl O Acta Oncol; 2001; 40(1):56-62. PubMed ID: 11321662 [TBL] [Abstract][Full Text] [Related]
40. Mutations of p53 gene in gastric carcinoma in Taiwan. Wang JY; Lin SR; Hsieh JS; Hsu CH; Huang YS; Huang TJ Anticancer Res; 2001; 21(1B):513-20. PubMed ID: 11299797 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]